medigraphic.com
ISSN 1561-3003 (Electronic)

2015, Number 2

<< Back Next >>

Rev Cubana Hig Epidemiol 2015; 53 (2)

Mortality due to lung cancer and ischemic heart disease attributable to passive smoking in Cuba-2011

Varona PP, García RG, Willams FA, Britton J

Language: Spanish
References: 33
Page:
PDF size: 81.55 Kb.


ABSTRACT

Introduction: Passive smoking increases the risk of contracting lung cancer and ischemic heart disease, and is responsible for totally avoidable mortality.
Objective: Estimate the mortality due to lung cancer and ischemic heart disease attributable to passive smoking in Cuba in the year 2011.
Method: Estimation was performed of the risk of passive smoking for lung cancer and ischemic heart disease, as well as of the population attributable fraction for mortality due to passive smoking. Mortality data were obtained from the National Health Statistics. Information about exposure to second-hand smoke in the population was collected from the 3rd National Survey about risk factors for non-communicable diseases. Deaths were stratified by sex and age group (35-64, 65 and over) at three exposure sites: the home, the workplace and both.
Results: There were 1 498 deaths in the year 2011 attributable to exposure to second-hand smoke: 145 (10%) were due to lung cancer and 1 353 (90%) to heart disease. Of the total number of deaths, 831 (55%) corresponded to women and 287 to the 35-64 age group. 848 deaths (57%) were attributable to exposure only in the home, 173 (11%) at work, and 477 (32%) in both places.
Conclusions: Passive smoking causes considerable avoidable mortality in Cuba. It is urgent to implement more energetic intersectoral actions as well as effective regulatory-educational strategies with an emphasis on the home aimed at creating smoke-free environments.
Contribution made by this publication: This is the first assessment of the impact of second-hand smoke on mortality due to lung cancer and heart disease in Cuba.


REFERENCES

  1. Hirayama TG. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. BMJ. 1981;282:183-5.

  2. CDC. The health consequences of smoking: a report of the surgeon general. Atlanta, GA: US Department of Health and Human Services, CDC;2006. [Citado el 30 de octubre de 2012] Disponible en: http://www.cdc.gov/tobacco/data statistics/sgr/2006/index/htm

  3. Oberg M, Jaakkola M, Woodword A, Peruga A, Pruss A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. The Lancet, 2011;(377):139-46.

  4. Institute of Medicine. Secondhand smoke exposure and cardiovascular effects: making sense of the evidence. Washington, 2009. [Citado el 13 de agosto de 2010] Disponible en:http://www.iom.edu/reports/2009/secondhand-smoke-exposure-andcardiovascular- eff ects-making-sense-of-the-evidence.aspx

  5. Ezzati M, Lopez AD. Smoking and oral tobacco use. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative quantification of health risks. Geneva: WHO, 2004. [Citado el 22 de febrero de 2010] Disponible en:http://www.who.int/healthinfo/global_burden_disease/cra/en/index.html

  6. Global estimate of the burden of disease from second-hand smoke MattiasOberga, Alistair Woodwardb, Maritta S. Jaakkolac, Armando Perugad, Annette Pruss-Ustune. World Health Organization. 2010.

  7. Öberg M, Jaakkola MS, Prüss-Ustün A, Woodward A. Second-hand smoke: assessing the burden of disease at national and local levels. Geneva: World Health Organization. 2010. [Citado el 7 de julio de 2010] Disponible en: http://www.who.int/quantifyingehimpacts/publications/ebd18/en/index.html

  8. Organización Mundial de la Salud. Convenio Marco de la OMS para el Control del Tabaco, 2003. Ginebra, 2005.

  9. Royal College of Physicians. Going smoke-free: the medical case for clean air in the home, at work and in public places. A report on passive smoking by the Tobacco Advisory Group of the Royal College of Physicians. London: RCP; 2005.

  10. Mackay D, Haw S, Ayres JG, Fischbacher C, Pell JP. Smoke-free Legislation and Hospitalizations for Childhood Asthma. N Engl J Med. 2010;363:1139-45.

  11. Mackay DF, Irfan MO, Haw S, Pell JP. Meta-analysis of the effect of comprehensive smoke-free legislation on acute coronary events. Heart 2010;96:1525-30.

  12. Millett C, Lee JT, Laverty AA, Glantz SA, Majeed A. Hospital Admissions for Childhood Asthma After Smoke-Free Legislation in England. Pediatrics. 2013;131:495- 501.

  13. Sebri EM, Sandoya E, Hyland A, Bianco E, Glantz SA, Cummings KM. Hospital admissions for acute myocardial infarction before and after implementation of a comprehensive smoke-free policy in Uruguay. Tobacco Control. 2013;22:16-20.

  14. Peruga A. Protección contra la exposición al humo de tabaco ajeno: recomendaciones de la OMS. Salud Publica México,2007 suplemento;49(2):315-17.

  15. World Health Organization. Ambientes 100 % libres de humo. WHO, Geneva, 2007.

  16. Organización Panamericana de la Salud. Concientizar al público sobre los peligros del humo de tabaco de los demás. Washington, D.C: OPS, 2004.

  17. Soto JG, Rojas J. TABAQUISMO PASIVO. Revista Española de Patología Torácica. 2010;22(1):5-43.

  18. Varona P, García R, Molina E, Bonet M. Humo ambiental de tabaco en el hogar y percepción de riesgo en la población cubana. Rev Cub Hig Epidemiol. 2010;48

  19. Bonet Gorbea M, Varona Pérez P, Chang La Rosa M, García Roche RG, Suárez Medina R, Arcia Montes de Oca N, et. al. III Encuesta de factores de riesgo y actividades preventivas de enfermedades no transmisibles. Cuba 2010-2011. [Internet]. La Habana: Editorial Ciencias Médicas; 2014. [Citado el 16 de febrero de 2014] Disponible en:http://www.bvs.sld.cu/libros/encuesta_nacional_riesgo/encuesta_nacional_complet o.pdf

  20. Instituto Nacional de Higiene, Epidemiología y Microbiología INHEM. Informe técnico II Encuesta Nacional de FR de ENT, 2001. La Habana, 2012.

  21. Lancés L. y Cols. Informe Técnico sobre Encuesta Mundial Sobre Tabaquismo en jóvenes. Cuba 2010. MINSAP, 2010.

  22. Jamrozik K. Estimate of deaths attributable to passive smoking among UK adults: database analysis. BMJ. 2005;330:812.

  23. Lopez MJ, Perez M, Nebot M, Montes A, Ariza C, et al. Mortality attributable to passive smoking in Spain, 2002.Tob Control, 2007;16:373-7.

  24. Ministerio de Salud Pública. Anuario Estadístico. La Habana;2012.

  25. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. Br Med J. 1997;315:980-8.

  26. Wells AJ.Heart disease from passive smoking in workplace. J Am Coll Cardiol. 1998;31:1-9.

  27. Steenland K. Risk assessment for heart disease and workplace ETS exposure among nonsmokers. Environ Health Perspect.1 999;107(Suppl 6):859-63.

  28. Instituto Nacional de Higiene, Epidemiología y Microbiología INHEM. Informe técnico ¨Impacto de la mortalidad atribuible al tabaquismo en la población cubana. Año 2012. La Habana, 2013.

  29. Heidrich J, Wellmann J, Heuschmann P, Kraywinkel K, Keil U. Mortality and morbidity from coronary heart disease attributable to passive smoking. European Heart Journal.2007; (28):2498-2502.

  30. López JM, Nebot M. Tabaquismo pasivo: cuántas muertes causa en España? Agencia de Salud Pública de Barcelona. JANO. 2009;1 (737):21-23.

  31. International Agency for Research on Cancer. Evaluating the effectiveness of smoke-free policies. Lyon: International Agency for Research on Cancer, 2009. [Citado el 22 de diciembre de 2009] Disponible en: http://www.iarc.fr/en/publications/pdfsonline/prev/handbook13/handbook13.pdf

  32. Menzies D, Nair A, Williamson PA, et al. Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. JAMA. 2006;296:1742-48.

  33. Pell JP, Havi S, Cobbe S, Newby DE, Peli ACH, Fischbacher C, et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008;359:482-91.




2020     |     www.medigraphic.com